Luye Pharma Group Ltd. | Mutual Funds
Mutual Funds that own Luye Pharma Group Ltd.
First State Global Umbrella Fd. Plc - China Growth Fund
70,380,000
2.15%
0
1.53%
09/30/2017
FTIF SICAV - Templeton Asian Smaller Companies Fund
29,851,100
0.91%
-2,043,500
1.7%
06/30/2018
Vanguard Emerging Markets Stock Index Fund
25,696,098
0.79%
-210,000
0.03%
07/31/2018
UBS (Lux) Equity Fund - China Opportunity
23,397,116
0.71%
0
0.59%
01/31/2018
Vanguard Total International Stock Index Fund
23,045,070
0.7%
0
0.01%
07/31/2018
Worldwide Healthcare Trust Plc
21,121,416
0.65%
-237,363
0.96%
09/30/2017
FTIF SICAV - Templeton Emerging Markets Smaller Companies
11,473,000
0.35%
-7,701,500
1.08%
06/30/2018
iShares Core MSCI Emerging Markets ETF
11,144,000
0.34%
0
0.02%
09/05/2018
Templeton Emerging Markets Small Cap Fund
10,634,000
0.33%
0
1.11%
03/31/2018
DFA Emerging Markets Small Cap Series
9,943,500
0.3%
0
0.13%
01/31/2018
| Address |
No. 15 Chuang Ye Road
Yantai Shandong 264003
China
|
|
Employees
|
- |
| Website |
http://www.luye.cn |
| Updated |
07/08/2019 |
| Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China. |
